<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-2448</journal-id>
<journal-title><![CDATA[Acta Medica Colombiana]]></journal-title>
<abbrev-journal-title><![CDATA[Acta Med Colomb]]></abbrev-journal-title>
<issn>0120-2448</issn>
<publisher>
<publisher-name><![CDATA[Asociacion Colombiana de Medicina Interna]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-24482017000400215</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Saturación de oxígeno/fracción inspirada de oxígeno como predictor de mortalidad en pacientes con exacerbación de EPOC atendidos en el Hospital Militar Central]]></article-title>
<article-title xml:lang="en"><![CDATA[Oxygen saturation / fraction of inspired oxygen as a predictor of mortality in patients with exacerbation of COPD treated at the Central Military Hospital]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mantilla]]></surname>
<given-names><![CDATA[Barbarita Maria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[Carlos Arturo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valbuena]]></surname>
<given-names><![CDATA[Sebastián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[Lilian]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hincapié]]></surname>
<given-names><![CDATA[Gustavo Adolfo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bastidas]]></surname>
<given-names><![CDATA[Alírio Rodrigo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Militar Nueva Granada Hospital Militar Central ]]></institution>
<addr-line><![CDATA[Bogotá D.C]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de la Sabana Clínica Universidad de la Sabana ]]></institution>
<addr-line><![CDATA[Bogotá D.C]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>42</volume>
<numero>4</numero>
<fpage>215</fpage>
<lpage>223</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-24482017000400215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-24482017000400215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-24482017000400215&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: la validez de la relación saturación arterial de oxígeno y fracción inspiratória de oxígeno (SaO2/FiO2), calculada por oximetría de pulso y por gases arteriales en pacientes con exacerbación de la enfermedad pulmonar obstructiva crónica (E-EPOC) a la altitud de Bogotá no son conocidos, los pacientes con EPOC pueden presentar alteraciones en el intercambio de gases que pueden empeorar con los episodios de broncoespasmo, obtener valores de la SaO2 por oximetría y FiO2 puede brindar información valiosa sobre el curso de la exacerbación.  Objetivo: determinar la validez de la relación SaO2/FiO2 calculada por oximetría de pulso y por gases arteriales con relación a los desenlaces de ventilación mecánica (VM) y mortalidad a siete y 30 días.  Métodos: se realizó un estudio de cohorte prospectivo con análisis de prueba diagnóstica calculando los puntajes DECAF, BAP-65, CURB-65, gases arteriales y oximetría de pulso al ingreso de pacientes con E-EPOC, se evaluó el desenlace de mortalidad a los siete y 30 días de ingreso y el requerimiento de VM durante su hospitalización, se calculó la relación SaO2/FiO2 utilizando la SaO2 obtenida en los gases arteriales y de manera independiente la relación SaO2/FiO2 con la SaO2 obtenida por oximetría de pulso, con los datos obtenidos se calculó los valores de sensibilidad (S), especificidad (E), valor predictivo positivo (VPP), valor predictivo negativo (VPN), razón de verosimilitud positiva (LR+), razón de verosimilitud negativa (LR-) y área bajo la curva de características operativas del receptor (ACOR).  Resultados: se analizaron 462 E-EPOC, el requerimiento de VM fue de 14.3% y mortalidad a 30 días de 5.71%, la sensibilidad de la relación SaO2/FiO2 calculada por oximetría de pulso para desenlace de VM fue de 84.6% (IC95%:75-94.2), especificidad 42% (IC95%:37- 47), VPP: 19.6% (IC95%:14.8-24.4), VPN: 94.3% (IC95%:90.5-98), LR+: 1.46 (IC95%:1.28-1.67), LR: 0.37(IC95%:0.20-1.67), ACOR: 0.779% (IC95%:0.711-0.847) p&lt;0.0001, la sensibilidad de relación SaO2/FiO2 por gases arteriales para VM fue de 83% (IC95%:73.2-92.9), especificidad 57% (IC95%:51.9-62.2), VPP: 24.8% (IC95%:18.8-30.7), VPN: 95.2% (IC95%:92.2-98.2), LR+: 1.94 (IC95%:1.65-2.27), LR-: 0.30 (IC95%:0.17-0.51), ACOR: 0.799% (IC95%:0.737-0.861) p&lt;0.0001, la sensibilidad de la relación SaO2/FiO2 por oximetría para desenlace de mortalidad tiene una sensibilidad del 76.8% (IC95%:58.8-95), especificidad de 39.2% (IC95%:34.4-43.9), VPP: 7.1% (IC95%:3.9-10.3), VPN: 96.5% (IC95%:93.5-99.5), LR+: 1.26 (IC95%:1.01-1.58), LR-: 0.59 (IC95%:0.29-1.20), ACOR: 0.689% (IC95%:0.568-0.810) p&lt;0.0001, la sensibilidad de la relación SaO2/FiO2 por gases arteriales para mortalidad fue de 80.8% (IC95%:63.7-97.8), especificidad 53.2% (IC95%:48.3-58), VPP: 9.6% (IC95%:5.5-13.8), VPN: 97.8% (IC95%:95.7-99.9), LR+: 1.73 (IC95%:1.39-2.14), LR-: 0.36 (IC95%:0.16-0.80), ACOR: 0.732% (IC95%:0.617-0.846) p&lt;0.0001.  Conclusión: los valores de SaO2/FiO2 calculados por oximetría y por gases arteriales pueden ser útiles para predecir desenlaces de VM y mortalidad en pacientes con exacerbación de la EPOC. (Acta Med Colomb 2017; 42: 215-223).]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: the validity of the ratio arterial oxygen saturation and inspiratory oxygen fraction (SaO /FiO2), calculated by pulse oximetry and by arterial gases in patients with exacerbation of chronic obstructive pulmonary disease (E-COPD) at the altitude of Bogotá are not known. Patients with COPD can present alterations in gas exchange that can worsen with bronchospasm episodes. Obtaining values of SaO2 by oximetry and FiO2 can provide valuable information on the course of the exacerbation.  Objective: to determine the validity of the SaO2/ iO2 ratio calculated by pulse oximetry and by arterial gases in relation to mechanical ventilation (VM) outcomes and mortality at seven and 30 days.  Methods: a prospective cohort study with diagnostic test analysis was performed, calculating DECAF, BAP-65, CURB-65, arterial blood gas and pulse oximetry scores on admission of patients with E-COPD, and the outcome of mortality was evaluated at seven and 30 days of admission and the MV requirement during hospitalization; the SaO2/FiO2 ratio was calculated using the SaO2 obtained in the arterial gases and independently the SaO2/FiO2 ratio with the SaO2 obtained by pulse oximetry. With the data obtained, the values of sensitivity (S), specificity (E), positive predictive value (VPP), negative predictive value (NPV), positive likelihood ratio (LR +), negative likelihood ratio (LR-) and low area the operating characteristics curve of the receiver (ACOR) were calculated.  Results: 462 E-COPD were analyzed; the MV requirement was 14.3% and 30-day mortality of 5.71%, the sensitivity of the SaO2/FiO2 ratio calculated by pulse oximetry for MV outcome was 84.6% (95% CI : 75-94.2), specificity 42% (95% CI: 37-47), PPV: 19.6% (95% CI: 14.8-24.4), NPV: 94.3% (95% CI: 90.5-98), LR +: 1.46 (95% CI : 1.28-1.67), LR: 0.37 (95% CI: 0.20-1.67), ACOR: 0.779% (95% CI: 0.711-0.847) p &lt;0.0001, sensitivity of SaO2/FiO2 ratio for arterial blood gases for MV was 83% (95% CI: 73.2-92.9), specificity 57% (95% CI: 51.9-62.2), PPV: 24.8% (95% CI: 18.8-30.7), NPV: 95.2% (95% CI: 92.2-98.2), LR +: 1.94 (IC95%: 1.65-2.27), LR-: 0.30 (IC95%: 0.17-0.51), ACOR: 0.799% (IC95%: 0.737-0.861) p &lt;0.0001, the sensitivity of the SaO2/FiO2 ratio by oximetry for outcome of mortality has a sensitivity of 76.8% (95% CI: 58.895), specificity of 39.2% (95% CI: 34.4-43.9), PPV: 7.1% (95% CI: 3.9-10.3), NPV: 96.5% (95% CI : 93.5-99.5), LR +: 1.26 (IC95%: 1.01-1.58), LR-: 0.59 (CI 95%: 0.29-1.20), ACOR: 0.689% (IC95%: 0.568-0.810) p &lt;0.0001, the sensitivity of the SaO2/FiO2 ratio for arterial blood gases was 80.8% (95% CI: 63.7-97.8), specificity 53.2% (95% CI: 48.3-58), PPV: 9.6% (95% CI: 5.5-13.8), NPV: 97.8% (95% CI: 95.7-99.9), LR +: 1.73 (95% CI: 1.39-2.14), LR-: 0.36 (IC95%: 0.16-0.80), ACOR: 0.732% (IC95%: 0.617-0.846) p &lt;0.0001.  Conclusion: SaO2/FiO2 values calculated by oximetry and arterial blood gases can be useful to predict MV outcomes and mortality in patients with exacerbation of COPD. (Acta Med Colomb 2017; 42: 215-223).]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[saturación arterial de oxígeno]]></kwd>
<kwd lng="es"><![CDATA[enfermedad pulmonar obstructiva crónica]]></kwd>
<kwd lng="es"><![CDATA[sensibilidad y especificidad]]></kwd>
<kwd lng="es"><![CDATA[puntaje]]></kwd>
<kwd lng="en"><![CDATA[arterial oxygen saturation]]></kwd>
<kwd lng="en"><![CDATA[chronic obstructive pulmonary disease]]></kwd>
<kwd lng="en"><![CDATA[sensitivity and specificity]]></kwd>
<kwd lng="en"><![CDATA[score]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1997</year>
<volume>349</volume>
<numero>9064</numero>
<issue>9064</issue>
<page-range>1498-504</page-range><publisher-loc><![CDATA[London, England ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lokke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lange]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Scharling]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Fabricius]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vestbo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Developing COPD a 25 year follow up study of the general population]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2006</year>
<volume>61</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>935-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Wedzicha]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COPD exacerbations 1 Epidemiology]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2006</year>
<volume>61</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>164-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Echevarria]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Steer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Heslop-Marshall]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Stenton]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Hickey]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2016</year>
<volume>71</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>133-40</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bourke]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The DECAF Score predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2012</year>
<volume>67</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>970-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roche]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chavaillon]]></surname>
<given-names><![CDATA[J-M]]></given-names>
</name>
<name>
<surname><![CDATA[Maurer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zureik]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Piquet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A clinical in-hospital prognostic score for acute exacerbations of COPD]]></article-title>
<source><![CDATA[Respiratory Research]]></source>
<year>2014</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>99</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Xiao]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Xia]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of Various Scoring Systems for Predicting the 28-Day Survival Rate among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Emergency Intensive Care]]></article-title>
<source><![CDATA[Canadian Respiratory Journal]]></source>
<year>2017</year>
<page-range>3063510</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shafuddin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cooray]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tuffery]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hopping]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[European Respiratory Journal]]></source>
<year>2016</year>
<numero>48^s60</numero>
<issue>48^s60</issue>
<supplement>60</supplement>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Mullerova]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Locantore]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hurst]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Calverley]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Vestbo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated with change in exacerbation frequency in COPD]]></article-title>
<source><![CDATA[Respir Res]]></source>
<year>2013</year>
<volume>14</volume>
<page-range>79</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ruan]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations a nationwide population-based study]]></article-title>
<source><![CDATA[PloS one]]></source>
<year>2014</year>
<volume>9</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lowe]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pearson]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence for a link between mortality in acute COPD and hospital type and resources]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2003</year>
<volume>58</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>947-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Esteban]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Anzueto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Frutos]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Alia]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Brochard]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics and outcomes in adult patients receiving mechanical ventilation a 28-day international study]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2002</year>
<volume>287</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>345-55</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hillas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Perlikos]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Tzanakis]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute exacerbation of]]></article-title>
<source><![CDATA[COPD: is it the &#8220;stroke of the lungs&#8221;?]]></source>
<year>2016</year>
<volume>11</volume>
<page-range>1579-86</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rusinowicz]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Zielonka]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Zycinska]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Cardiac Arrhythmias in Patients with Exacerbation of COPD. Advances in experimental medicine and biology]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shorr]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Johannes]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Derby]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Tabak]]></surname>
<given-names><![CDATA[YP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting the need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease Comparing the CURB-65 and BAP-65 scores]]></article-title>
<source><![CDATA[Journal of critical care]]></source>
<year>2012</year>
<volume>27</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>564-70</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singanayagam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Schembri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Annals of the American Thoracic Society]]></source>
<year>2013</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>81-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qaseem]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wilt]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Weinberger]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Hanania]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Criner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of stable chronic obstructive pulmonary disease a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society]]></article-title>
<collab>van der Molen T</collab>
<source><![CDATA[Annals of internal medicine]]></source>
<year>2011</year>
<volume>155</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>179-91</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cameron]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pilcher]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Weatherall]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Beasley]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Perrin]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The risk of serious adverse outcomes associated with hypoxaemia and hyperoxaemia in acute exacerbations of COPD]]></article-title>
<source><![CDATA[Postgraduate medical journal]]></source>
<year>2012</year>
<volume>88</volume>
<numero>1046</numero>
<issue>1046</issue>
<page-range>684-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia-Gutierrez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Unzurrunzaga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arostegui]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Pulido]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gallardo]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Use of Pulse Oximetry to Determine Hypoxemia in Acute Exacerbations of COPD]]></article-title>
<source><![CDATA[COPD]]></source>
<year>2015</year>
<volume>12</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>613-20</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[McAlpine]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kyle]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How accurate are pulse oximeters in patients with acute exacerbations of chronic obstructive airways disease]]></article-title>
<source><![CDATA[Respiratory medicine]]></source>
<year>2001</year>
<volume>95</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>336-40</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Runciman]]></surname>
<given-names><![CDATA[WB]]></given-names>
</name>
<name>
<surname><![CDATA[Webb]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Barker]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Currie]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Australian Incident Monitoring Study The pulse oximeter: applications and limitations--an analysis of 2000 incident reports]]></article-title>
<source><![CDATA[Anaesthesia and intensive care]]></source>
<year>1993</year>
<volume>21</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>543-50</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laishley]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Aps]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tension pneumothorax and pulse oximetry]]></article-title>
<source><![CDATA[British journal of anaesthesia]]></source>
<year>1991</year>
<volume>66</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>250-2</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Masip]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gaya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Paez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Betbese]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vecilla]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Manresa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulse oximetry in the diagnosis of acute heart failure]]></article-title>
<source><![CDATA[Revista Española de Cardiología (English ed)]]></source>
<year>2012</year>
<volume>65</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>879-84</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Casas]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Bastidas]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveros]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Pinilla]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Calderón]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Indices de oxigenación como predictores de ventilación mecánica en neumonía a 2600 metros de altitud]]></article-title>
<source><![CDATA[Acta Médica Colombiana]]></source>
<year>2016</year>
<volume>41</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dalbak]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Straand]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Melbye]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Should pulse oximetry be included in GPs&amp;apos; assessment of patients with obstructive lung disease]]></article-title>
<source><![CDATA[Scandinavian journal of primary health care]]></source>
<year>2015</year>
<volume>33</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>305-10</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
